Haemonetics 3rd Quarter Fiscal 2019 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Haemonetics (HAE) Sell-Off Overdone - Jefferies
February 5, 2019 12:40 PM ESTJefferies analyst Anthony Petrone came out to defend Haemonetics (NYSE: HAE) calling the sell-off overdone and providing a good entry point.
The high-level sticking points are: 1) implicit plasma guide for F2020; 2) pace of NexSys contracting; and 3) level of spend in Q and... More
Haemonetics (HAE) Tops Q3 EPS by 4c, Revenues Miss; Offers FY19 EPS Mid-Point Guidance Below Consensus
February 5, 2019 6:11 AM ESTHaemonetics (NYSE: HAE) reported Q3 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $247 million versus the consensus estimate of $250.13 million.
Chris Simon, Haemonetics CEO, stated: Our third quarter performance met our expectations
and reinforces that our... More
